Navigation Links
Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis

five patients had detectable CsA levels below 0.33ng/ml, a value which is considered as negligible

These results are presented at the occasion of a Symposium chaired by Pr BenEzra, lead coordinator of the study.

About Novagali Pharma Vekacia(R):

Vekacia(R) is a Cyclosporine A ophthalmic product intended for patients suffering from vernal keratoconjunctivitis. Vekacia(R) is a proprietary cationic emulsion enabling an efficient and unmatched-level drug absorption in tissues of the eye leading to optimal therapeutic efficacy.

About Novagali Pharma: www.novagali.com

Novagali Pharma SA is an emerging ophthalmic pharmaceutical company based in the Genopole biocluster in Evry, France, that develops innovative products for all segments of the eye. Thanks to its proprietary technology platforms Novasorb(R) and Eyeject(R), the company has developed a broad pipeline of innovative products addressing main ocular conditions as well as orphan diseases. Most advanced products include Vekacia(R), an orphan product for treatment of vernal keratoconjunctivitis; Cationorm(R), a CE marking product for dry eye relief; and Nova22007, a product for the treatment of moderate-to-severe dry eye syndrome. Founded in 2000, the firm has raised a total amount of Euro 44 million in 3 series of financing and currently has 38 employees.

    Contacts Presse

    Novagali

    VP HR & Communication

    Genevieve Garrigos

    +33-1-69-87-40-20

    


    Euro RSCG

    Estelle Griffe

    +33-1-58-47-95-25 / +33-6-23-75-09-23

    



genevieve.garrigos@novagali.com Estelle.griffe@eurorscg.fr

Nova Gali Pharma

CONTACT: Contacts Presse: Novagali, VP HR & Communication, GenevieveGarrigos, +33-1-69-87-40-20, ; Euro RSCG,Estelle Griffe, +33-1-58-4
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Novagali Pharma Announces Positive Vekacia Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:5/22/2015)... May 22, 2015 Richmond ... research unit with a worldwide reputation for excellence ... frequent publications in peer reviewed medical journals. Its ... and regulators in discussions about rules for transparency ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research ...
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain ... a leading retail drugstore chain in China ... stores, today announced the resignation of Mr. Fuxiang ... personal reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... the Company,s board of directors, effective immediately. Meanwhile, Ms. ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Fulcrum Ventures announced today that they invested $1.25 million in Path-Tec, LLC.  Founded in ... management and patient specimen tracking.  Based in Columbus, Georgia , Path-Tec positions itself as a complete outsourcing ... ... , ...
... WASHINGTON , March 22 Allan Coukell , director of the Pew Prescription Project, issued the following statement ... device companies to publicly report the gifts and payments they make to doctors.   , ... ... ...
Cached Medicine Technology:Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC 2Fulcrum Ventures Leads $1.25 Million Investment in Path-Tec, LLC 3Pew Statement on the Physician Payments Sunshine Act 2
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel ... York City, to speak at Burke on Wednesday, June 3. ... Lobby Lecture series, will take place at 4:30 p.m. on ... grandson of Stanford White of McKim, Mead and White, the ... 100 years ago. , “We are thrilled to welcome Samuel ...
(Date:5/24/2015)... For people who are keen on the Enterokinase ... Research Report would be an useful report to refer ... present market scenario of this industry. The report also ... of this industry. The report summarizes key statistics of ... in this industry. The report is a valuable source ...
(Date:5/24/2015)... ProPin is a set of self-animating ... Utilize ProPin to pin point locations on a map, to ... , ProPin allows users to choose from 30 simplistic presets with ... on-screen controls, video editors can easily manipulate ProPin presets as a ... with absolute ease. , Using ProPin is easy, simply drag a ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers are ... City exactly five years to the day after the disastrous ... large fire tore through the Branches United Methodist Church and ... middle of the night as neighbors, staff and Branches' children ... though it is suspected that the fire began accidentally. Branches ...
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... found the mechanism through which lipoic acid may help people ... vigour, free of degenerative disease, until very near death. ... process of ageing, improve blood flow, enhance immune function, and ... suggests that lipoic acid is actually a low-level stressor that ...
... Chemotherapy is a standard regimen in most cancer treatments. Since ... to replace it with something more comfortable for the ... the drug Zoladex switch off the ovary and stop the ... grow. ,An agonist achieves a normal action, often ...
... that the cox-2 inhibitor celecoxib, a common pain reliever used ... most common cause of brain damage in premature babies. ... part of the brain that in premature infants is very ... on an approximate 12,000 children a year, leaving many everlastingly ...
... the National Cancer Institute and Fred Hutchinson Cancer ... found in tomatoes , does not effectively prevent ... noted an association between beta-carotene, an antioxidant related ... prostate cancer. ,It is disappointing, since ...
... effort to strengthen and sustain its leadership in the companion ... of Wisconsin-Madison will establish a new Stem Cell and ... center, to be made today (May 17) at a public ... the cloned sheep Dolly, sets the stage for a critical ...
... making addition of folic acid to flour or bread mandatory in ... disabilities. ,After lengthy public consultations the Food Standards Agency ... recommendations next month after it decides whether folic acid should be ... accept the FSA's proposals, it will be the first time since ...
Cached Medicine News:Health News:Lipoic Acid may Help to Live Long, Free of Degenerative Disease 2Health News:A Fresh Alternative to Painful Chemotherapy Developed in UK 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 2Health News:Common Pain Killer may Reduce the Risk of Brain Damage in Premature Babies 3Health News:Tomatoes are Not So Effective in Preventing Prostate Cancer 2Health News:UW Establishes Stem Cell and Regenerative Medicine Center 2Health News:UK too Will Insist on Folic Acid in Bread 2Health News:UK too Will Insist on Folic Acid in Bread 3
Solid 16 mm blades. Self-locking mechanism. Dull finish....
... speculum has wide solid blades ... clearance for the suction ring. ... lids and lashes to clear ... The blades are curved to ...
Angled 45 degrees. Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Solid 21 mm blades. Screw-controlled locking mechanism. Dull finish....
Medicine Products: